laboratory-shot-1

The Cancer Therapeutics structural biology team draws on 50-plus years of protein crystallography knowledge and has successfully determined the structures of several target proteins and protein/inhibitor complexes.

As well as high quality in-house crystallization labs, Cancer Therapeutics has access to the Australian Synchrotron and multiple X-ray facilities (Rigaku MicroMax 007HF with RAXIS4++ area detector and cryocooling).